Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine supply
Pharma
After cuts, Novavax's Q4 performance startles investors
As Novavax emerges from its “transition year” in 2023, the vaccine maker is still raising concerns among Wall Street investors in early 2024.
Fraiser Kansteiner
Feb 28, 2024 9:38am
Novavax paying up to $400M to evade Gavi COVID shot arbitration
Feb 22, 2024 6:00am
Pfizer adds another country to its list of COVID shot lawsuits
Jan 19, 2024 9:22am
Emergent lines up BARDA pact to supply anthrax shot in the US
Nov 28, 2023 4:20pm
Pfizer sues Poland over alleged missed COVID-19 vaccine payments
Nov 28, 2023 12:02pm
Pfizer takes $5.6B in Paxlovid, Comirnaty inventory write-offs
Oct 31, 2023 10:12am